Synthetic cannabinoids screen with confirmation-12521

Test info

  
Synthetic cannabinoids screen with confirmation
  
12521
  
LAB12521
  
THC
  
JWH-018
JWH-073
JWH-122
JWH-250
K2
RCS-4
Spice
SYN CANNA UR
  

Qualitative synthetic cannabinoid analysis includes metabolites of the following:

  • AB-CHMINACA
  • AB-FUBINACA
  • AB-PINACA
  • F-AB-PINACA
  • ADBICA
  • 5F-ADBICA
  • ADB-PINACA
  • 5F-ADB-PINACA
  • AKB-48
  • 5Cl-AKB-48
  • 5F-AKB-48
  • AM2201
  • AM694
  • BB-22
  • BB-22 hydroxyquinolines
  • JWH-018
  • JWH-073
  • JWH-122
  • JWH-250
  • MAB-CHMINACA
  • MAM-2201
  • PB-22
  • PB-22 hydroxyquinolines
  • 5F-PB-22
  • 5F-PB-22-hyroxyquinolines
  • UR-144
  • XLR-11

Positive initial results reflex to additional testing with an additional charge

  

This test is intended for use in the clinical management of patients. It is not intended for use in employment related testing.

Detection of the use of synthetic cannabinoid drugs

  

For order by Allina Health facilities and Allina Health contracted clients only

Specimen

  
Urine, random
  
  
10.0 mL
  
1.0 mL
  

Transfer a 10mL (minimum 1.0 mL) aliquot of random urine to a Urine transfer vial/tube (MedTox)

  
  

Refrigerated (preferred)

Ambient (OK) - 3 days

Frozen (OK)

  
  • Urines collected with preservative will be rejected

Performance

  
MedTox Laboratories (701106): R-MX
  
Daily
  
5 - 6 days
  

Screen: Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) at a testing threshold of 1.0 ng/mL

Confirmation: definitive Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)

Clinical and Interpretive info

  

Negative

Screening threshold: 1.0 ng/mL

Billing

  
80307
  
Yes
  

Tracking

  
05/30/2014
  
08/04/2022
  
12/28/2023